New York, NY – According to filings with the U.S. Securities and Exchange Commission, Cleerly is raising $230,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, James Min played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cleerly
Cleerly is a digital healthcare company creating a world without heart attacks. We design intelligent clinical technologies to help clinicians precisely identify and define heart disease earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis itself plaque build-up in the hearts arteries not its indirect markers. Our AI-driven digital care platform offers simpler, faster, more accurate heart disease diagnostics and reporting that’s tailored to each stakeholder, improving overall clinical and financial outcomes.

To learn more about Cleerly, visit http://cleerlyhealth.com/

Contact:
James Min, President and Chief Executive Officer
917-238-0569
james.min@cleerlyhealth.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved